Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C Trial.
Martine T E PutsNaser AlquriniFay J StrohscheinRama KoneruEwa SzumacherCaroline MarianoJohanne MonetteTina HsuSarah BrennenstuhlBianca McLeanAria WillsArielle S BergerEitan AmirLindy RomanovskyAnson LiRajin MehtaMonika K KrzyzanowskaChristine ElserRaymond JangAnca PricaDoreen Wan-Chow-WahEric PittersUrban EmmeneggerInes B MenjakSimon BergmanManon LemondeHenriette BreunisFrancois BélandShabbir Muhammad Husayn AlibhaiPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
GAM did not improve QOL. Most intervention group participants received GA on or after treatment initiation per patient request. Considering recent completed trials, GA may have benefit if completed before treatment selection. The COVID-19 pandemic may have affected our QOL outcome and intervention delivery for some participants.